Wang Xue-Yan, Koller Romana, Wirth Michael, Gabor Franz
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria.
Sci Pharm. 2014 Feb 8;82(1):193-205. doi: 10.3797/scipharm.1312-08. Print 2014 Jan-Mar.
PLGA microparticles loaded with three different fluorescent model drugs, fluorescein sodium (hydrophilic), sulforhodamine (amphoteric), and boron-dipyrromethene (BODIPY(®) 493/503, lipophilic), were prepared by the solvent evaporation technique. Due to varying hydrophilicity, the diameters of the microparticles ranged between 4.1 and 4.7 μm. According to fluorimetric analysis, the loading varied from 0.06 to 2.25 μg of the model drug per mg PLGA. In terms of the release profile, the fluorescein sodium-entrapped formulation exhibited thermo-responsive release kinetics. In the case of sulforhodamine- and BODIPY(®) 493/503-loaded particles, almost no release was observed, neither at 4°C nor 37°C during the first 50 hours. Furthermore, to estimate the bioadhesive properties of such drug delivery systems, the surface of the loaded particles was grafted with wheat germ agglutinin by applying the carbodiimide method. Cytoadhesion studies with Caco-2 monolayers revealed an up to 1.9-fold and 3.6-fold increase in the bioadhesion of the lectin-functionalized, model drug-loaded particles as compared to the albumin- and non-grafted microcarriers, respectively. All in all, the results clearly indicated that the lipophilicity of the polymer matching that of the drug favored entrapment, whereas mismatching impeded loading into the PLGA-microparticles. Even in the case of low loading, these delivery systems might be useful for the fluorescent detections and microscopic imaging of cellular interactions due to their fluorescent properties and lack of dye leakage. Moreover, lectin grafting can mediate bioadhesive properties to such particulate drug carriers which could be a promising approach to improve drug delivery.
采用溶剂蒸发技术制备了负载三种不同荧光模型药物的聚乳酸-羟基乙酸共聚物(PLGA)微粒,这三种药物分别是荧光素钠(亲水性)、磺基罗丹明(两性)和硼二吡咯亚甲基(BODIPY(®) 493/503,亲脂性)。由于亲水性不同,微粒直径在4.1至4.7μm之间。根据荧光分析,每毫克PLGA中模型药物的负载量在0.06至2.25μg之间。就释放曲线而言,包载荧光素钠的制剂表现出热响应释放动力学。对于负载磺基罗丹明和BODIPY(®) 493/503的微粒,在最初50小时内,无论在4°C还是37°C下,几乎都未观察到释放。此外,为了评估此类药物递送系统的生物黏附特性,通过应用碳二亚胺法,在负载微粒的表面接枝了麦胚凝集素。与Caco-2单层细胞进行的细胞黏附研究表明,与白蛋白包被的微载体和未接枝的微载体相比,凝集素功能化的、负载模型药物的微粒的生物黏附性分别提高了1.9倍和3.6倍。总而言之,结果清楚地表明,聚合物与药物的亲脂性匹配有利于包封,而不匹配则会阻碍药物负载到PLGA微粒中。即使在负载量较低的情况下,这些递送系统因其荧光特性和无染料泄漏,可能对细胞相互作用的荧光检测和显微镜成像有用。此外,凝集素接枝可赋予此类颗粒药物载体生物黏附特性,这可能是改善药物递送的一种有前景的方法。